Found: 12
Select item for more details and to access through your institution.
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0298-y
- By:
- Publication type:
- Article
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2672, doi. 10.3390/cancers16152672
- By:
- Publication type:
- Article
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 982, doi. 10.3390/cancers14040982
- By:
- Publication type:
- Article
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S248, doi. 10.1016/j.clml.2019.07.153
- By:
- Publication type:
- Article
The Daratumumab Crosses the Blood Brain Barrier.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S289, doi. 10.1016/j.clml.2018.07.229
- By:
- Publication type:
- Article
Stopping Prophylactic Antiviral Therapy after Remission, Between the Lack of Attention and the Lack of Clear Guidelines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S220, doi. 10.1016/j.clml.2018.07.088
- By:
- Publication type:
- Article
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 1042, doi. 10.1002/ajh.25154
- By:
- Publication type:
- Article
Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA.
- Published in:
- Lymphoma (2090309X), 2014, p. 1, doi. 10.1155/2014/205215
- By:
- Publication type:
- Article
Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 3, p. 338, doi. 10.1111/j.1365-2141.2005.05777.x
- By:
- Publication type:
- Article
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 1004, doi. 10.1002/cncr.34005
- By:
- Publication type:
- Article